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Abstract
Background & Aims—Klotho deficiency in hypomorphic KL mice leads to premature
senescence and phenotype consistent with impaired mineral homeostasis. Klotho has anti-
inflammatory properties protecting from NO-induced endothelial dysfunction, reduces the
expression of endothelial adhesion molecules, and may contribute to T-cell dysfunction. Since
defective Ca2+/Pi homeostasis leading to osteopenia/osteoporosis is frequently associated with
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human IBD, we investigated the changes in Klotho gene expression as a consequence of
experimental colitis.
Methods—We utilized three murine IBD models: TNBS colitis, microflora-induced colitis in
gnotobiotic IL-10−/− mice, and adoptive CD4+CD45RBhigh T-cell transfer colitis. These studies
were followed by in vitro approaches using renal epithelial cells (mpkDCT4 and mIMCD3), and
the cloned murine KL gene promoter.
Results—Renal expression of Klotho mRNA and protein was significantly inhibited in all three
models of human IBD. This degree of inhibition was correlated with the severity of colitis, and
was reversed by neutralizing anti-TNF antibodies. In vitro, TNF resulted in a significant inhibition
of KL expression and was further potentiated by IFN-γ. TNF/IFN-γ combination resulted in
increased iNOS expression and significantly elevated the concentration of NO in medium. The
effect of IFN-γ could be reproduced by cell exposure to SNAP (NO donor), and reversed by iNOS
inhibitor, L-NIL. The cytokine effects were transcriptionally mediated since Klotho mRNA
stability remained unaffected, while reporter constructs with the mKL gene promoter displayed
significant downregulation in transiently transfected renal epithelial cells.
Conclusions—These novel findings could help explain several extraintestinal complications
including abnormalities in bone homeostasis in patients with chronic colitis.
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Introduction
α-Klotho was initially identified in mice after an unrelated transgene was fortuitously
inserted into the 5′ flanking region of the α-Kl gene, thus creating a hypomorphic allele
with dramatically reduced Kl expression in homozygous mice. Klotho hypomorphs present
many accelerated age-related disorders that mimic human aging including a short lifespan,
infertility, arteriosclerosis, ectopic calcification, skin atrophy, osteoporosis and
emphysema1. The Kl gene encodes a 130 kDa type I membrane protein, predominantly
expressed in kidney distal convoluted tubules, with its large extracellular domain composed
of two repeats that share sequence homology with members of the β-glycosidase family,
with relatively weak β-glucuronidase activity2. The extracellular repeats can be
enzymatically cleaved from the membrane and released in detectable quantities into the
cerebrospinal fluid or circulating blood3. A second klotho variant of approximately 70 kDa
exists as the result of alternative splicing which removes half of the C-terminal end together
with the membrane binding domain. Among the several functions attributed to this gene are:
regulation of Ca2+/Pi homeostasis, regulation of insulin-like growth factor 1 (IGF1)
signaling, reduction of oxidative stress through de-repression of forkhead box O (FOXO)
transcription factors, and protection of the endothelium through induction of eNOS, and
inhibition of TNF-α induced NF-κB activity and expression of endothelial adhesion
molecules4–5.
The contribution of Kl to mineral homeostasis is complex. Due to the described β-
glucuronidase activity, Klotho positively affects active renal Ca2+ reabsorption by
stabilizing and increasing the activity of TRPV5 (transient receptor potential vanilloid 5)
calcium channel. Klotho-mediated removal of the terminal sialic acids from TRPV5 N-
glycan chains leads to galectin-1 binding to TRPV5, which decreases TRPV5 endocytosis,
and enhances its retention at the cell surface6–7, thus leading to increased renal Ca2+
reabsorption. Klotho may also indirectly affect transepithelial Ca2+ through α-Klotho-
dependent surface recruitment of Na+/K+-ATPase in response to low extracellular ionized
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Ca2+8. This mechanism has been implicated in enhancing the release of PTH in response to
decreased extracellular calcium ([Ca2+]o) 9, an event that leads to a rapid increase in renal
Ca2+ reabsorption. Impaired Klotho expression and activity would likely affect the
regulation of electrochemical gradients in the plasma membrane, since the fluctuations of
Na+/K+-ATPase activity determine the activities of other ATPases, ion channels, and ion
exchangers from the Ca2+/cation antiporter superfamily, such as NCX and NCKX.
α-Klotho participates in the signaling mechanism for FGF23, a potent circulating,
osteoblast-derived phosphaturic hormone. Klotho binding converts the FGF receptors
(FGFR1c, FGFR3c, and FGFR4) from its inactive to a high affinity state10–11, thus
permitting FGF23 to exert its physiological functions. One of these is inhibition of
1,25(OH)2D3 synthesis (the active metabolite of vitamin D)12–13. It is now believed that
overproduction of 1,25(OH)2D3 may be the primary effector of the aging-like phenotype in
KL-deficient mice14.
By extension, Klotho may also be an indispensable co-factor in FGF23-mediated induction
of phosphaturia through inhibition of the apical expression and activity of the NaPi-IIa, a
Na+/Pi cotransporter in the proximal tubule epithelium15 and inhibition of the intestinal Pi
absorption via decreased activity and brush border membrane expression of NaPi-IIb in the
intestine16, although these mechanisms have not been directly investigated.
Several other physiological functions have been attributed to Klotho, such as protection
against endothelial dysfunction by regulating NO production, or participation in intracellular
signaling pathways including p53/p21, cAMP, protein kinase C (PKC) and Wnt signaling.
These have been recently and comprehensively reviewed elsewhere 4.
The wide spectrum of Klotho biological activities suggests that its dysregulated expression,
particularly under inflammatory conditions, could have profound consequences. Renal
expression of Klotho has been shown to be downregulated in the rat model of acute LPS-
mediated inflammatory stress 17. The spleen and other immune organs from Klotho
knockout mice are underdeveloped and B-cell development and differentiation are
impaired1, 18. Expression of Klotho protein was described on the surface of human CD4+
lymphocytes19, where it was significantly decreased proportionally to the advancing age, but
it was also heavily suppressed in the CD4+ cells of rheumatoid arthritis (RA) patients. A
similar association of Klotho in the immune cells of patients with idiopathic inflammatory
bowel disease (IBD), a disease sharing many commonalities with RA, has not been
investigated. The latter group of inflammatory disorders is of particular interest due to high
occurrence of osteopenia and osteoporosis as two of the main extraintestinal complications
of chronic IBD20. The pathogenesis of the metabolic bone disease in IBD is likely
multifactorial with contributing factors including altered Pi, Ca2+ and vitamin D3
homeostasis, inflammatory cytokines, glucocorticoid treatment, decreased gonadal function
and overall poor nutrition and low physical activity. Our group has recently demonstrated a
detrimental effect of experimental colitis and TNF on intestinal Pi absorption21 and on
osteoblast expression of the Phex gene22, effects likely contributing to defective bone
mineralization in IBD-related metabolic bone disease.
Here, we demonstrate that renal Kl expression is repressed in three distinct animal models of
acute and chronic colitis, and implicate the role of TNF and IFN-γ in the mechanism of this
inhibition. A decrease in Klotho expression correlated with the disease severity and could be
ameliorated by anti-TNF antibody. In the in vitro studies with immortalized distal
convoluted tubule epithelial cells, TNF and IFN-γ inhibited Kl gene transcription, with IFN-
γ potentiating the effects of TNF by induction of iNOS and NO production. These results
provide the first evidence of the IBD-associated inflammatory process adversely affecting
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renal expression of Klotho, an event with potentially profound systemic consequences,
including mineral homeostasis, vascular health and aging.
Methods
Reagents
The sources of major reagents used in the study are listed in detail in the Supplement.
Murine colitis models
TNBS colitis was induced in BALB/c mice as described earlier23. A subgroup of TNBS
treated mice was administered a neutralizing hamster anti-mouse monoclonal anti-TNF
antibody (clone TN3–19.12; azide-free, endotoxin level <.001; eBioscience, San Diego,
CA). 250 μg of the antibody were injected intraperitoneally 4 hours before induction of
colitis and 3 days following induction. Mice that died before day 7 were not included in the
experiment. On day 7 post-induction, mice were sacrificed by CO2 narcosis followed by
cervical dislocation.
Specific pathogen-free wild type (WT) 129/SvEv mice and germ-free IL-10−/− mice on the
same genetic background were obtained from the National Gnotobiotic Rodent Resource
Center at the University of North Carolina, Chapel Hill. Germ-free IL-10−/− mice were
transferred to the SPF facility and kept in sterile cages two days prior to colonizing them
with SPF fecal bacteria. Mice were sacrificed 8 weeks post-colonization to allow
development of moderate to severe colitis.
Adoptive T-cell transfer colitis was induced by intraperitoneal injection of 0.5×106 naïve,
flow-sorted (FACSAria, Beckton-Dickinson, Franklin Lake, NJ) CD4+CD45RBhigh
lymphocytes (98% purity) into Rag-2−/− host (both C57BL/6)24. Control (PBS-injected) and
colitic mice were sacrificed 8 weeks after transfer.
All methods in this study were approved by the Institutional Animal Care and Use
Committee of the University of Arizona or the University of North Carolina at Chapel Hill.
Evaluation of colitis and sample collection
Mice were monitored for weight loss as well as signs of rectal bleeding and diarrhea.
Paraffin-embedded sections were taken from the proximal and distal colon and histological
damage was evaluated by a veterinary pathologist in an unbiased fashion in hematoxylin-
eosin (H&E)-stained sections as described previously 25–26. Direct visualization of the colon
in vivo was performed using a “Coloview system” (Karl Storz Veterinary Endoscopy) as
described 27. At the end of the experimental period, kidneys were extracted, flash frozen in
liquid nitrogen, and stored at −70°C for RNA and protein isolation. Sections of the proximal
and distal colon were used for tissue explant cultures and cytokine ELISA as described
earlier28 and briefly explained in the supplement. Mesenteric lymph node cells were
prepared and stimulated ex vivo with CD3/CD28 antibodies as described in the supplement.
Cell Culture
Immortalized mouse distal convoluted tubule cells (mpkDCT) were generated in A.
Vandewalle’s laboratory by microdissection from a SV-PK/Tag transgenic mouse and
cultured as described earlier29. Mouse inner medullary collecting duct (mIMCD-3) cell line
derived from a mouse transgenic for the early region of SV40 [Tg(SV40E)bri/7]30 were
obtained from American Type Culture Collection (ATCC, Manassas, VA) and cultured in
DMEM:F12 medium with 10% fetal bovine serum. Cells were treated with TNF (20 ng/mL)
and/or IFN-γ (100 U/mL) for 2–24 hours. RNA stability studies required a 30 minute
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pretreatment with actinomycin D (ActD; 1 ng/mL) prior to addition of cytokines. For nitric
oxide donor experiments, SNAP (a nitric oxide donor) was added to the medium, and
medium containing SNAP was replaced every 5 hours for a combined 20 hour exposure. At
completion, medium was collected for a nitrate/nitrite assay using the Nitric Oxide
Quantitation kit according to manufacturer’s protocol (Active Motif, Carlsbad, CA), while
cells were washed with PBS and used for RNA isolation.
RNA Extraction and Real-time RT-PCR
Total renal RNA was extracted and Klotho, iNOS, TBP, or β-Actin mRNA expression was
analyzed by real-time RT-PCR as described in more detail in ref. 31 and in the Supplement.
Klotho immunoblotting and ELISA
Western blot and ELISA analysis of renal Klotho protein is described in more detail in the
Supplement. The developed ELISA protocol was reliable and reproducible with kidney
lysates, but failed to detect circulating Klotho in mouse serum, likely due to sensitivity
issues, or epitope targeting.
mKlotho reporter gene construct and transfections
1099 nt fragment of the murine Klotho gene regulatory sequence spanning -1085 nt to +14
nt relative to the described transcription start site32 was amplified from mouse genomic
DNA using the following primers: forward 5′-
CTTTGAGCCTCGAGATGTTTCCCAATGAAT-3′ and the reverse 5′-
GCCCTCCCGGCTCCCGCAGCAAGCTTGCCCG-3′, with XhoI and HindIII adapters,
respectively. The amplicon was ultimately subcloned into pGL4.72-basic plasmid (Promega)
using pGEM-T Easy cloning plasmid (Promega, Madison, WI) as a shuttle vector. pGL4.72
plasmid contains a Rapid Response Renilla luciferase (hrLucCP), engineered to include the
protein degradation sequences hCL1 and hPEST. Shorter 5′-deletion constructs were made
in the same fashion and were fully sequenced to confirm fidelity. mIMCD3 cells were then
transfected with 0.2 ug the promoter constructs using TransIT-LT reagent (Mirus) in 24-well
plates according to manufacturer’s protocol. 16 hours post- transfection, cells were
incubated with vehicle or TNF and/or IFN-γ for 24 hours, luciferase activity was measured
using the Renilla Luciferase activity assay (Promega), and normalized to protein
concentrations.
Statistical Analysis
Statistical significance was determined by the Student’s t-test or analysis of variance
(ANOVA) followed by Fisher’s protected least significant difference (PLSD) test, using the
Statview software package version 4.53 (SAS Institute; Cary, NC). Data are expressed as
means ± S.E.
Results
Downregulation of Klotho in TNBS colitis
TNBS colitis is an acute remitting model of hapten-induced colonic inflammation
characterized by weight loss, rectal bleeding, mucosal neutrophilic and lymphocytic
infiltration, mucosal erosions and in severe cases, death. The progression of the disease is
quite variable in mice, ranging from extreme moribundity to nearly complete recovery on
day 7 post-administration. Within the limitations of this model, it allowed us to not only
assess the average expression of Klotho in all experimental mice, but to correlate the extent
of inflammation/recovery with the degree of inhibition of renal Klotho expression. In all
studied mice (n=9), TNBS colitis resulted in significant inhibition of Klotho mRNA (Fig.
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1A) and protein (Fig. 1B) expression in the kidney, an effect which was completely
abrogated by treatment with a neutralizing anti-TNF antibody (Fig. 1A). However,
exogenous TNF injected at a dose sufficient to inhibit expression of the Phex gene in the
bone [15μg/100g body weight22) was not sufficient to reproduce the effects of colitis on
Klotho expression (Fig. 1C). Analysis of individual colitic animals demonstrated significant
variation in the extent of this inhibition, which highly correlated with the body weight loss
and the histological mucosal damage, as exemplified by data from animals #4–6 in Fig. 1D
and 1E. ELISA analysis failed to detect the circulating soluble form of Klotho in mouse
serum (data not shown).
Downregulation of Klotho in IL-10 deficiency colitis
Germ-free IL-10−/− mice and genetically matched wild-type control were transferred to SPF
conditions and colonized with SPF microflora two days later. After 8 weeks, WT mice
showed no evidence of macroscopic inflammation and displayed a semi-translucent mucosa
with well-defined vascularization associated with a healthy colon (Fig. 2A, upper panel) as
assayed by miniature endoscopy. In contrast, IL-10−/− mice exhibited mucosal thickening
and loss of apparent vasculature associated with macroscopic intestinal inflammation (Fig.
2A, lower panel). Consistent with previously published data [28, 33], histological analysis of
the proximal and distal colon of IL-10−/− mice 8 weeks post-colonization showed a
characteristic pattern of inflammation associated with crypt hyperplasia, lymphocytic and
neutrophilic infiltrations and mucosal ulceration with varying degrees of severity. The
cumulative histological scores (proximal and distal segments) showed enhanced
inflammation in IL-10−/− mice at 8 weeks compared to WT mice (8.6±1.89 vs. 1.1±0.4,
p<0.001). Renal Klotho mRNA (Fig. 2B) and protein expression (Fig. 2C) was decreased by
60% in IL-10−/− mice 8 weeks post-colonization.
Downregulation of Klotho in adoptive T-cell transfer colitis
Adoptive transfer of CD4+CD45RBhigh T-cells (naïve T-cells) from healthy wild-type mice
into syngeneic recipients that lack T- and B-cells induces pancolitis and small bowel
inflammation within 5–8 wk with symptoms resembling human Crohn’s disease. The
CD45RBhigh T-cell transfer led to significantly reduced renal Klotho expression (Fig. 3A)
coinciding with moderate-to-severe chronic colitis, characterized by increased mucosal
thickness and transmural infiltration of lymphocytes, monocytes, macrophages, and
granulocytes, affecting both proximal and distal colon (Fig. 3B). Production of selected
cytokines (IFN-γ, TNF, IL-1β, and IL-17) was significantly elevated in the supernatants
obtained from unstimulated colonic explants cultures as well as from CD3/CD28-stimulated
MLN lymphocyte culture (Fig. 3C).
In vitro, IFN-γ and TNF potently reduce Klotho expression in mpkDCT4 cells
To further examine the possible role of proinflammatory cytokines in the downregulation of
Klotho, immortalized mouse epithelial cells of distal convoluted tubule origin, mpkDCT4,
were treated with selected proinflammatory cytokines (TNF, IL-1β, IL-6, IFN-γ) alone or in
combination. All but IL-6 were able to significantly inhibit KL mRNA expression (data not
shown). A combination treatment of all cytokines (cytomix) resulted by the most significant
decrease of approximately 60% (p<.001), which could be mimicked by selective
combination of TNF and IFN-γ (data not shown and Fig. 4). To examine the dynamics of
these two cytokines, Klotho expression was analyzed over time by real-time RT-PCR (0 –
24hr). We observed some latency of the TNF effect with a significant decrease in Klotho
mRNA at 4–8 hours after treatment and nadir at 8–16 hours (Fig. 5A). A combination of
TNF and IFN-γ not only further decreased the expression of Klotho, but also accelerated the
decline which manifested at just 2 hours following treatment.
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Nitric Oxide mediates the downregulation of Klotho by IFN-γ
The potentiating effects of IFN-γ on the TNF-mediated inhibition of Klotho gene expression
in mpkDCT4 cells coincided with a dramatic increase in expression of iNOS (Fig. 5B) and
NO production, which level remained stably elevated between 2–24 hours of treatment (Fig.
5C). To determine whether nitric oxide was sufficient in downregulating Klotho expression,
mpkDCT4 cells were treated with increasing concentrations of a NO donor (SNAP) for 20
hours at increasing concentrations. We observed a concentration-dependent decrease of
Klotho mRNA expression (Fig. 6A). 50 μM of SNAP resulted in cumulative NO production
reaching 33 μM in medium (Fig. 6B), comparable with ~25μM NO observed after TNF/
IFN-γ treatment, and resulting in 77% reduction of Klotho expression (Fig. 6A).
Furthermore, in mpkDCT4 cells, the iNOS inhibitor, L-NIL, effectively reversed the IFN-γ-
induced, but not TNF-induced inhibition of Klotho expression (Fig. 7A). The effect of TNF
was reversible with curcumin, a broad spectrum inhibitor of NF-κB and MAPK pathways
(Fig. 7A).
JNK kinase mediates the inhibitory effects of TNF and IFN-γ
To follow up on the protective effects of curcumin we tested the role of NF-κB in the
cytokine-mediated reduction of Klotho expression. Inhibition of NF-κB signaling in
mpkDCT4 cells with BAY11–7082 ((E)3-[(4-Methylphenyl)sulfonyl]-2-propenenitrile), a
potent and irreversible inhibitor of TNF-induced IκBα phosphorylation, remained without
effect on both the TNF and IFN-γ-induced decrease of Klotho (data not shown). However,
selective inhibition of c-Jun N-terminal kinase (JNK) with 1,9-pyrazoloanthrone
(SP600125) reversed the negative effects of TNF and IFN-γ used alone or in combination
(Fig. 7B).
TNF and IFN-γ affect Klotho at the level of gene transcription
To further dissect the effects of TNF and IFN-γ on Klotho mRNA expression, we first
determined the effect of the cytokines on the Klotho transcript RNA stability. De novo gene
transcription was inhibited in mpkDCT4 with ActD prior to and during cytokine treatment
and the decline of Klotho transcript (as a measure of mRNA degradation) was assessed by
real-time RT-PCR. Neither cytokine (nor their combination) affected the rate of Klotho
transcript degradation (Fig. 8A), thus implicating a transcriptional mechanism. We therefore
cloned the 5′ regulatory region of the murine Klotho gene and generated several 5′ deletion
constructs to test their responsiveness to the two cytokines in transiently transfected renal
epithelial cells. Immortalized mpkDCT4 cells were very difficult to transfect (including the
Amaxa nucleofection technique) and yielded poorly reproducible and low reporter activity
values. mIMCD-3 cells, originally isolated from the mouse medullary collecting ducts,
expressed lower levels of Klotho, but reacted in a similar fashion to TNF, and IFN-γ in
terms of Klotho and iNOS gene expression (Fig. 8B), and were more amenable to transient
transfection techniques. In mIMCD-3 cells transfected with Klotho promoter constructs,
TNF effectively reduced the activity of the construct spanning −1085/+14nt, but not the
−785/+14 nt of the mKL promoter (Fig. 8C), thus suggesting an important regulatory
element within −1085/−786nt region driving the effects of TNF. All shorter constructs
reacted to IFN-γ alone or the combination of the cytokines. The construct containing -273nt
upstream of the transcription start site was the most active, and appeared to contain the
necessary cis-elements required for INF-γ-mediated inhibition of gene transcription. The
visible additive effects of IFN-γ and TNF in the constructs containing -785nt and shorter
may be related to TNF-induced expression of IFN-γ receptor subunits reported in other
systems33. Fig. 8C also depicts prediction analysis of the transcription factor binding sites
within the -1085nt fragment of the murine Klotho promoter, with a particular emphasis on
prototypical JNK pathways targets, AP-1, Elk-1 and ATF transcription factors (Match™
software and Transfac transcription factor binding site matrices).
Thurston et al. Page 7














Extraintestinal manifestations occur in approximately one-third of the IBD patients with
joints, skin, eyes and biliary tract most commonly involved. Many extraintestinal disorders
may be direct inflammatory and metabolic complications of the intestinal inflammation (i.e.,
osteoporosis, growth retardation, nephrolithiasis, or thromboembolic disease). Despite the
rapid progress in understanding the pathogenesis and consequences of IBD, the line between
direct and indirect systemic effects of chronic intestinal inflammation remains less defined.
In this study, we provide the first evidence of experimental colitis negatively affecting
expression of Klotho, a gene involved not only in the pathogenesis of aging, but also
involved in mineral homeostasis and vascular protection. Since renal biopsy is not indicated
in IBD, and since no single animal model of colitis is fully representative of human IBD, we
employed three distinct models of the disease to demonstrate decreased expression of
Klotho. These include the haptenizing model of TNBS colitis, IL-10 deficiency colitis, and
the immune model of adoptive T-cell transfer into Rag2−/− mice. We showed that the degree
of Klotho inhibition is related to the severity of colitis and that attenuation of inflammation
with a neutralizing anti-TNF antibody prevented this inhibition. A combination of in vivo
and in vitro approaches further demonstrated that IFN-γ potentiates the effects of TNF via
induction of iNOS and via the suppressive effect of NO. These effects were JNK-dependent
and involved transcriptional repression of the Klotho gene promoter.
In another report, a similar inhibition of Klotho was demonstrated in vivo in a rat model of
endotoxemia17, although the results could not be confirmed in vitro in embryonic HEK239
kidney cells or in human renal proximal tubular epithelial cells (RPTEC). The interpretation
of these results is difficult, since Klotho is normally not expressed in the proximal tubules,
and our own observations indicate that expression of Klotho in HEK293 cells is below
detection limit (real-time RT-PCR, unpublished data).
Transcriptional inhibition of Klotho expression in the kidney, an organ considered to be the
major site of Klotho expression and the primary source of the circulating protein, would
likely result in diminished circulating levels of Klotho. As discussed below, the
consequences of this decrease may be wide and significant, and will have to be addressed
experimentally. At this point, we can only predict these consequences based on data from
the documented in vitro effects of Klotho, and from the phenotype of the Klotho
hypomorphic mice. The latter may be difficult to compare, however, due to different degrees
of inhibition (ca. 50% in colitis vs. 90% in Klotho mice), and the developmental
complications due to early onset of Klotho deficiency in Kl/Kl mice.
Klotho has been shown to affect Wnt signaling by inhibition of various Wnt family
members34. Disinhibition of Wnt signaling has been shown to contribute to stem and
progenitor cell senescence and chronically reduced Klotho expression may influence the rate
of cellular aging and negatively affect tissue repair mechanisms. Klotho protein also protects
cells and tissues from oxidative stress, possibly through de-repression of FOXO
transcription factors35. Klotho insufficiency may therefore adversely affect not only vascular
endothelium, but also colonic epithelium in IBD. Recent data demonstrates that FOXO-4 not
only protects from the development of experimental colitis, but also participates in the
inhibition of NF-κB activity in colonic epithelial cells36. Moreover, Klotho was also
recently reported to inhibit TNF-induced NF-κB and vascular adhesion molecule expression
in endothelial cells5. It is, therefore, not inconceivable, that diminished expression of Klotho
could feed back to further exacerbate the inflammation.
Perhaps the most fascinating aspect of Klotho physiology is its role in mineral homeostasis.
Similar to a significant number of IBD patients who develop osteopenia and osteoporosis37,
Thurston et al. Page 8













Klotho hypomorphs also develop osteoporosis, likely secondary to elevated levels of
1,25(OH)2D314. Interestingly, despite the overall consensus that hypovitaminosis D is
prevalent in IBD patients (based on 25(OH)D3 levels as an indication of vitamin D
nutritional status)38, as much as 42% of Crohn’s patients have been reported to have
abnormally elevated levels of 1,25(OH)2D3, correlating with increased expression of 1α-
OHase in the inflamed gut39. It is important to note that under limited Ca2+ and Pi
availability (impaired intestinal absorption), and particularly in the presence of inflammatory
cytokines promoting osteoclast differentiation, 1,25(OH)2D3 may act to stimulate bone
turnover to maintain serum Ca2+ at the expense of bone mineral density. Such impaired
intestinal absorption has been long postulated and reduced expression of key intestinal Pi
and Ca2+ transporters in experimental IBD has been recently confirmed by our group21 and
by others38. It is tempting to speculate that decreased Klotho contributes to the de-repression
of 1α-OHase expression and increased 1,25(OH)2D3 production in active IBD due to a
defective FGF23 signaling mechanism. On the other hand, impaired FGF23 function in
Klotho insufficiency could be viewed as beneficial, since it would lead to inhibition of
phosphaturic effects of FGF23. These are normally mediated by inhibition of NaPi-IIa,
which along with NaPi-IIc provides the major route for renal Pi re-absorption. This
phosphate sparing mechanism is unlikely, however, due to the observed concomitant
increase of circulating FGF23, and significant decrease in renal expression of NaPi-IIa and
NaPi-IIc in TNBS and T-cell transfer colitis (own unpublished observations).
Decreased Klotho expression could also have a profound effect on Ca2+ homeostasis
through impaired [Ca2+]o sensing and PTH release from the parathyroid gland and through
potentially impaired function of TRPV5 in the distal convoluted tubules, where Klotho acts
to stabilize TRPV5 on the apical membrane through removal of sialic acid and enabling the
interaction with galectin-1 6. Recent data confirms renal Ca2+ wasting in Klotho-deficient
mice40.
Conclusions
We provide novel data describing inhibition of Klotho expression in mouse models of
inflammatory bowel disease. This finding may have broad implications not only for IBD and
the associated changes in mineral homeostasis, but also for other systemic complications of
this and other chronic inflammatory conditions. While the pathophysiological consequences
and causative relationship of decreased Klotho will have to be experimentally addressed, our
findings lay the foundation for future work related to the contribution of Klotho to chronic
inflammatory diseases in human patients.
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TNBS trinitrobenzene sulfonic acid
iNOS inducible nitric oxide synthase
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FGF23 fibroblast growth factor 23
References
1. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome
resembling ageing. Nature. 1997; 390:45–51. [PubMed: 9363890]
2. Tohyama O, Imura A, Iwano A, et al. Klotho is a novel beta-glucuronidase capable of hydrolyzing
steroid beta-glucuronides. J Biol Chem. 2004; 279:9777–84. [PubMed: 14701853]
3. Imura A, Iwano A, Tohyama O, et al. Secreted Klotho protein in sera and CSF: implication for post-
translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004; 565:143–
7. [PubMed: 15135068]
4. Wang Y, Sun Z. Current understanding of klotho. Ageing Res Rev. 2009; 8:43–51. [PubMed:
19022406]
5. Maekawa Y, Ishikawa K, Yasuda O, et al. Klotho suppresses TNF-alpha-induced expression of
adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine. 2009;
35:341–6. [PubMed: 19367378]
6. Cha SK, Ortega B, Kurosu H, et al. Removal of sialic acid involving Klotho causes cell-surface
retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A. 2008; 105:9805–
10. [PubMed: 18606998]
7. Chang Q, Hoefs S, van der Kemp AW, et al. The beta-glucuronidase klotho hydrolyzes and
activates the TRPV5 channel. Science. 2005; 310:490–3. [PubMed: 16239475]
8. Razzaque MS. Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?
Nephrol Dial Transplant. 2008; 23:459–61. [PubMed: 17977876]
9. Imura A, Tsuji Y, Murata M, et al. alpha-Klotho as a regulator of calcium homeostasis. Science.
2007; 316:1615–8. [PubMed: 17569864]
10. Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by
klotho. J Biol Chem. 2006; 281:6120–3. [PubMed: 16436388]
11. Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific
receptor for FGF23. Nature. 2006; 444:770–4. [PubMed: 17086194]
12. Perwad F, Zhang MY, Tenenhouse HS, et al. Fibroblast growth factor 23 impairs phosphorus and
vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase
expression in vitro. Am J Physiol Renal Physiol. 2007; 293:F1577–83. [PubMed: 17699549]
13. Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism
and phosphate homeostasis. J Bone Miner Res. 2004; 19:429–35. [PubMed: 15040831]
14. Ohnishi M, Nakatani T, Lanske B, et al. Reversal of mineral ion homeostasis and soft-tissue
calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int.
2009; 75:1166–72. [PubMed: 19225558]
15. Baum M, Schiavi S, Dwarakanath V, et al. Effect of fibroblast growth factor-23 on phosphate
transport in proximal tubules. Kidney Int. 2005; 68:1148–53. [PubMed: 16105045]
16. Miyamoto K, Ito M, Kuwahata M, et al. Inhibition of intestinal sodium-dependent inorganic
phosphate transport by fibroblast growth factor 23. Ther Apher Dial. 2005; 9:331–5. [PubMed:
16076377]
17. Ohyama Y, Kurabayashi M, Masuda H, et al. Molecular cloning of rat klotho cDNA: markedly
decreased expression of klotho by acute inflammatory stress. Biochem Biophys Res Commun.
1998; 251:920–5. [PubMed: 9791011]
Thurston et al. Page 10













18. Okada S, Yoshida T, Hong Z, et al. Impairment of B lymphopoiesis in precocious aging (klotho)
mice. Int Immunol. 2000; 12:861–71. [PubMed: 10837414]
19. Witkowski JM, Soroczynska-Cybula M, Bryl E, et al. Klotho--a common link in physiological and
rheumatoid arthritis-related aging of human CD4+ lymphocytes. J Immunol. 2007; 178:771–7.
[PubMed: 17202338]
20. Ardizzone S, Puttini PS, Cassinotti A, et al. Extraintestinal manifestations of inflammatory bowel
disease. Dig Liver Dis. 2008; 40 (Suppl 2):S253–9. [PubMed: 18598997]
21. Chen H, Xu H, Dong J, et al. Tumor necrosis factor-alpha impairs intestinal phosphate absorption
in colitis. Am J Physiol Gastrointest Liver Physiol. 2009; 296:G775–81. [PubMed: 19196948]
22. Uno JK, Kolek OI, Hines ER, et al. The role of tumor necrosis factor alpha in down-regulation of
osteoblast Phex gene expression in experimental murine colitis. Gastroenterology. 2006; 131:497–
509. [PubMed: 16890604]
23. Billerey-Larmonier C, Uno JK, Larmonier N, et al. Protective effects of dietary curcumin in mouse
model of chemically induced colitis are strain dependent. Inflamm Bowel Dis. 2008; 14:780–93.
[PubMed: 18200517]
24. Ostanin DV, Bao J, Koboziev I, et al. T cell transfer model of chronic colitis: concepts,
considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009; 296:G135–
46. [PubMed: 19033538]
25. Karrasch T, Kim JS, Muhlbauer M, et al. Gnotobiotic IL-10−/−;NF-kappa B(EGFP) mice reveal
the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol.
2007; 178:6522–32. [PubMed: 17475882]
26. Kiela PR, Midura AJ, Kuscuoglu N, et al. Effects of Boswellia serrata in mouse models of
chemically induced colitis. Am J Physiol Gastrointest Liver Physiol. 2005; 288:G798–808.
[PubMed: 15539433]
27. Joo YE, Karrasch T, Muhlbauer M, et al. Tomato lycopene extract prevents lipopolysaccharide-
induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-
kappaBEGFP mice. PLoS One. 2009; 4:e4562. [PubMed: 19234608]
28. Larmonier CB, Uno JK, Lee KM, et al. Limited effects of dietary curcumin on Th-1 driven colitis
in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. Am J Physiol
Gastrointest Liver Physiol. 2008; 295:G1079–91. [PubMed: 18818316]
29. Diepens RJ, den Dekker E, Bens M, et al. Characterization of a murine renal distal convoluted
tubule cell line for the study of transcellular calcium transport. Am J Physiol Renal Physiol. 2004;
286:F483–9. [PubMed: 14625201]
30. Rauchman MI, Nigam SK, Delpire E, et al. An osmotically tolerant inner medullary collecting duct
cell line from an SV40 transgenic mouse. Am J Physiol. 1993; 265:F416–24. [PubMed: 8214101]
31. Kiela PR, Laubitz D, Larmonier CB, et al. Changes in Mucosal Homeostasis Predispose NHE3
Knockout Mice to Increased Susceptibility to DSS-Induced Epithelial Injury. Gastroenterology.
2009; 137(3):965–75. 975.e1–10. [PubMed: 19450596]
32. Shiraki-Iida T, Aizawa H, Matsumura Y, et al. Structure of the mouse klotho gene and its two
transcripts encoding membrane and secreted protein. FEBS Lett. 1998; 424:6–10. [PubMed:
9537505]
33. Shirey KA, Jung JY, Maeder GS, et al. Upregulation of IFN-gamma receptor expression by
proinflammatory cytokines influences IDO activation in epithelial cells. J Interferon Cytokine Res.
2006; 26:53–62. [PubMed: 16426148]
34. Liu H, Fergusson MM, Castilho RM, et al. Augmented Wnt signaling in a mammalian model of
accelerated aging. Science. 2007; 317:803–6. [PubMed: 17690294]
35. Yamamoto M, Clark JD, Pastor JV, et al. Regulation of oxidative stress by the anti-aging hormone
klotho. J Biol Chem. 2005; 280:38029–34. [PubMed: 16186101]
36. Zhou W, Cao Q, Peng Y, et al. FoxO4 Inhibits NF-kappaB and Protects Mice Against Colonic
Injury and Inflammation. Gastroenterology. 2009 In Print.
37. Tilg H, Moschen AR, Kaser A, et al. Gut, inflammation and osteoporosis: basic and clinical
concepts. Gut. 2008; 57:684–94. [PubMed: 18408105]
Thurston et al. Page 11













38. Huybers S, Apostolaki M, van der Eerden BC, et al. Murine TNF(DeltaARE) Crohn’s disease
model displays diminished expression of intestinal Ca2+ transporters. Inflamm Bowel Dis. 2008;
14:803–11. [PubMed: 18266230]
39. Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in
inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated
1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004; 53:1129–36. [PubMed:
15247180]
40. Alexander RT, Woudenberg-Vrenken TE, Buurman J, et al. Klotho Prevents Renal Calcium Loss.
J Am Soc Nephrol. 2009 In Print.
Thurston et al. Page 12













Figure 1. The effects of TNBS colitis on renal expression of Klotho
(A) Klotho mRNA expression in control mice, TNBS-treated mice, and mice treated with
TNBS and anti-TNF antibody. Anti TNF antibody was given to mice (250 μg/mouse) 4
hours prior to TNBS enema and again on day 3 after TNBS treatment. (n=6–8). (B) ELISA
analysis of renal Klotho protein in tissue lysates from control and TNBS-treated mice (n-=5)
(C) Exogenous recombinant murine TNF (15μg/100 g body weight) is not sufficient to
downregulate Klotho mRNA in vivo (n=3). Decreased expression of Klotho protein
correlates with the severity of colitis in individual TNBS-treated mice as exemplified in
mice selected (animal #4–6) by varying weight loss (D) and distal colonic histology (E).
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Figure 2. Progressing colitis in SPF-colonized germ-free IL-10−/− mice results in decreased renal
Klotho expression
(A) Representative microendoscopy picture of the distal colonic mucosa of WT mice, or
IL-10−/− mice 8 weeks after colonization with SPF microflora. (B) Real-time RT-PCR
analysis of renal expression of Klotho mRNA in WT and colitic IL-10−/− mice. Values
referred to age-matched wild-type (WT) mice maintained in SPF conditions (n=5–9; *
p<0.05 t-test WT vs. IL-10−/−). (C) Representative western blot analysis of Klotho protein in
the renal lysates of WT and IL-10−/− mice 8 weeks post-colonization.
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Figure 3. Renal Klotho expression is downregulated in the adoptive T-cell transfer model of
Crohn’s disease
0.5×106 naïve CD4+CD45RBhigh lymphocytes were transferred into Rag-2−/− host. Control
(PBS-injected) and colitic mice were sacrificed 8 weeks after transfer. (A) Real-time RT-
PCR analysis of renal Klotho mRNA expression in control and adoptively transferred mice
(n=4). (B) Representative H&E-stained sections of the proximal and distal colon in control
(PBS) mice and mice transferred with CD45RBhigh lymphocytes. (C) Secretion of IFN-γ,
TNF, IL-1β, and IL-17 by the MLN cells cultured in the presence of CD3/CD28 antibodies
(bars, left axis) and by the colonic explant cultures (dashed line, right axis). Asterisks
indicate statistical differences between groups (p<0.05 Student t-test; n=4).
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Figure 4. The effect of selected cytokines alone and in combination on Klotho mRNA expression
mpkDCT4 cells
Immortalized mouse distal convoluted tubule epithelial cells were treated with TNF (20ng/
mL), IL1β (10 ng/mL), IL-6 (10 ng/mL), IFN-γ (100U/mL), combination of TNF and IFN-
γ, or all four cytokines (Cytomix) for 24 hours. Klotho mRNA was analyzed by real-time
RT-PCR. (* p<0.05 control vs. cytokine treatment; # p<0.05 TNF vs. TNF/IFN-γ; ANOVA
followed by Fisher PLSD test; n=4).
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Figure 5. Time course analysis of the effects of TNF and TNF/IFN-γcombination on the
expression of Klotho, iNOS, and NO production in mpkDCT4 cells
Cells were treated for 2–24 hours with TNF (20ng/mL; open squares) or TNF/IFN-γ (20ng/
mL and 100U/mL, respectively; open triangles) and expression of Klotho (A) and iNOS (B)
was measured by real-time RT-PCR. (C) NO in the media was measured after conversion of
nitrate to nitrite using nitrite reductase and colorimetric Griess reaction (Active Motif Nitric
Oxide Quantitation Kit). (* p<0.05 control vs. cytokine treatment; # p<0.05 TNF vs. TNF/
IFN-γ; ANOVA followed by Fisher PLSD test; n=4).
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Figure 6. The effects of nitric oxide on Klotho expression in mpkDCT4 cells
Cells were treated with SNAP for 20 hours with medium changed every 5 hours. Klotho
expression was measured with real-time PCR (A) and the corresponding NO production was
measured in medium using Nitric Oxide Quantitation Kit (Active Motif) (B). (* p<0.05
control vs. SNAP treatment; values above bars in (B) indicate the mean NOx concentration
in medium).
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Figure 7. iNOS inhibitor L-NIL restores Klotho expression in IFN-γ-treated cells, while JNK
inhibition abrogates the effects of TNF, IFN-γ, or combination of the two cytokines
(A) Cells were pre-treated with 1mM L-NIL prior to addition of IFN-γ (100U/mL) or TNF
(20ng/mL) to the medium. Cells were harvested 24 hours later and Klotho expression was
analyzed by real-time RT-PCR. Curcumin (20μM) used as a non-specific inhibitor of NF-
κB and AP-1 effectively reversed both TNF-induced downregulation of Klotho expression.
(* p<0.05 control vs. cytokine treatment; n=4). (B). Cells were pretreated with a selective
inhibitor of JNK, 1,9-pyrazoloanthrone (SP600125; 20 μM) prior to 24-hr cytokine
treatment (TNF at 20ng/mL, IFN-γ at 100U/mL) and Klotho mRNA expression was
analyzed by real-time RT-PCR (* p<0.05 control vs. cytokine treatment; n=4).
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Figure 8. Klotho is regulated by TNF and/or IFN-γ via a transcriptional mechanism
(A) De novo transcription was inhibited in mpkDCT4 cells with Actinomycin D (ActD) and
Klotho transcript decay rate was followed over time by real-time RT-PCR analysis. No
significant differences were observed in the rate of mRNA degradation in control (open
circles), TNF-treated (open squares) or TNF/IFN-γ co-treated cells (open triangles). (B) The
effects of the two cytokines on Klotho (bars) and iNOS (line) expression in mIMCD-3 cells
mirrors the effects observed in the mpkDCT4 cells. (C) The effects of TNF, IFN-γ, and
their combination on murine Klotho gene promoter activity in transiently transfected
mIMCD-3 cells. 5′-deletion constructs spanning -1085nt to -273nt upstream of the
transcription start site are depicted with predicted binding sites for the three prototypical
JNK-regulated transcription factors, AP- 1,Elk-1, and ATF/CREB (* p<0.05 control vs.
cytokine treatment, n=4). Transcription start site, mapped by Shiraki-Iida et al.32 is
indicated by a right-pointing arrow.
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